Cyclopentanecarbohydrazide, with the CAS number 3400-07-5, is an organic compound characterized by the presence of a cyclopentane ring and a hydrazide functional group. It typically appears as a white to off-white crystalline solid. The compound is known for its potential applications in various fields, including pharmaceuticals and organic synthesis. Cyclopentanecarbohydrazide may exhibit properties such as moderate solubility in polar solvents and stability under standard laboratory conditions. Its structure allows for potential reactivity in condensation reactions, making it a useful intermediate in the synthesis of more complex molecules. Additionally, the hydrazide group can participate in various chemical transformations, including hydrazone formation and oxidation reactions. As with many hydrazides, it may also exhibit biological activity, although specific biological properties would require further investigation. Safety data should be consulted to ensure proper handling and usage in laboratory settings.

cyclopentanecarbohydrazide

3400-07-5: Cyclopentanecarboxylic Acid, Hydrazide

Cyclopentanecarbohydrazide is a metabolic disorder drug that is used in the treatment of cancer, including leukemia. It has been shown to inhibit the growth of cancer cells by binding to the CB1 receptor. Cyclopentanecarbohydrazide also shows anti-inflammatory effects and can be used for the treatment of inflammatory diseases such as psoriasis or Crohn's disease. Cyclopentanecarbohydrazide binds to glutamate, which is an excitatory neurotransmitter and activates a number of receptors in the brain. Cyclopentanecarbohydrazide can be used for the treatment of depression or type II diabetes mellitus (T2DM).

CAS 3400-07-5: cyclopentanecarbohydrazide

Cyclopentanecarbohydrazide

Ref: 3D-FC114123

Cyclopentanecarbohydrazide

Ref: 10-F061373